FR2118134A1 - - Google Patents

Info

Publication number
FR2118134A1
FR2118134A1 FR7145283A FR7145283A FR2118134A1 FR 2118134 A1 FR2118134 A1 FR 2118134A1 FR 7145283 A FR7145283 A FR 7145283A FR 7145283 A FR7145283 A FR 7145283A FR 2118134 A1 FR2118134 A1 FR 2118134A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7145283A
Other languages
French (fr)
Other versions
FR2118134B1 (en
Inventor
Victor Assad Najjar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ASSAD NAJJAR V
Original Assignee
ASSAD NAJJAR V
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ASSAD NAJJAR V filed Critical ASSAD NAJJAR V
Publication of FR2118134A1 publication Critical patent/FR2118134A1/fr
Application granted granted Critical
Publication of FR2118134B1 publication Critical patent/FR2118134B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1024—Tetrapeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
FR7145283A 1970-12-16 1971-12-16 Expired FR2118134B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US9889070A 1970-12-16 1970-12-16

Publications (2)

Publication Number Publication Date
FR2118134A1 true FR2118134A1 (en) 1972-07-28
FR2118134B1 FR2118134B1 (en) 1975-10-10

Family

ID=22271422

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7145283A Expired FR2118134B1 (en) 1970-12-16 1971-12-16

Country Status (7)

Country Link
US (1) US3778426A (en)
JP (1) JPS6053040B1 (en)
CA (1) CA999851A (en)
CH (1) CH605672A5 (en)
DE (1) DE2124003C2 (en)
FR (1) FR2118134B1 (en)
GB (1) GB1364497A (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008803A2 (en) * 1978-09-07 1980-03-19 Research Corporation Ovulation enhancing peptides and their pharmaceutical compositions
FR2597107A1 (en) * 1986-04-09 1987-10-16 Ellem Ind Farmaceutica TRIPEPTIDE HAVING AN IMMUNOSTIMULATING ACTIVITY
EP0335662A1 (en) * 1988-03-28 1989-10-04 Btg International Limited Peptides
EP0392095A2 (en) * 1989-02-10 1990-10-17 SCLAVO S.p.A. Tuftsin analogues and vaccines containing these as adjuvants
US5389615A (en) * 1988-03-28 1995-02-14 British Technology Group Ltd. Peptides and pharmaceutical composition thereof in the treatment of pain
EP1556074A2 (en) * 2001-08-30 2005-07-27 Chay 13 Medical Research Group N.V. Casein derived peptides and uses thereof in therapy

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3966701A (en) * 1973-11-07 1976-06-29 The Dow Chemical Company Fibrinogen peptide derivatives
US4001199A (en) * 1974-03-26 1977-01-04 Takeda Chemical Industries, Ltd. Novel polypeptides useful for treating diabetes and hypercholesteremia
US4073890A (en) * 1974-03-26 1978-02-14 Takeda Chemical Industries, Ltd. Novel polypeptides
US4016259A (en) * 1974-07-26 1977-04-05 Research Corporation Contraceptive polypeptides
SE407058B (en) * 1974-12-05 1979-03-12 Kabi Ab NEW CHROMOGENA ENZYME SUBSTRATE FOR SERINE PROTEASES
DE2602443A1 (en) * 1975-04-04 1976-10-21 Univ California BIOLOGICALLY ACTIVE POLYPEPTIDES
US4169015A (en) * 1975-07-11 1979-09-25 Ab Kabi Novel chromogenic thrombin substrates
US4061625A (en) * 1975-07-11 1977-12-06 Ab Kabi Novel chromogenic thrombin substrates
IT8021120A0 (en) 1979-04-02 1980-04-01 Inst Organicheskogo Sinteza Ak CYCLIC ANALOGUE OF THE NATURAL PEPTIDE THAT STIMULATES PHAGOCYTOSIS: THREONYL-CYCLE (N-LYSYL-PROLYL-ARGINYL).
US4752601A (en) * 1983-08-12 1988-06-21 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin FC receptors
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
US5028593A (en) * 1989-08-15 1991-07-02 Board Of Regents, The University Of Texas System Tuftsin analogs
IT1232311B (en) * 1989-09-04 1992-01-28 Sclavo Spa PURIFICATION METHOD OF LOW MOLECULAR PEPTIDIC OR PSEUDO PEPTIDIC STRUCTURE COMPOUNDS.
GB9211668D0 (en) * 1992-06-02 1992-07-15 Nycomed Bioreg As Peptide compounds
US7666996B2 (en) * 2000-03-01 2010-02-23 Peptera Pharmaceuticals Ltd Casein derived peptides and uses thereof
IL134830A0 (en) * 2000-03-01 2001-05-20 Chay 13 Medical Res Group N V Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
JP2010538989A (en) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト Use of NF-kappa B inhibitor SN50 as a therapeutic agent in the treatment of HBV infection and the like, and optionally use of angiotensin III
RU2507212C3 (en) * 2012-03-28 2022-05-04 Общество С Ограниченной Ответственностью "Айвикс" METHOD FOR PRODUCING RECOMBINANT PEPTIDE AND PRODUCED PEPTIDE
CN113413456A (en) * 2013-05-28 2021-09-21 Ovb(爱尔兰)有限公司 Method for producing recombinant peptides and resulting peptides
RU2626002C1 (en) 2016-10-24 2017-07-21 Общество С Ограниченной Ответственностью "Айвикс" New group of peptides for treatment of female sexual dysfunction
JP2018118973A (en) * 2018-02-23 2018-08-02 アイビックス・リミテッドＩｖｉｘ Ｌｔｄ． Method for producing recombinant peptide and resultant peptide

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0008803A2 (en) * 1978-09-07 1980-03-19 Research Corporation Ovulation enhancing peptides and their pharmaceutical compositions
EP0008803A3 (en) * 1978-09-07 1980-04-16 Research Corporation Ovulation enhancing peptides and their pharmaceutical compositions
FR2597107A1 (en) * 1986-04-09 1987-10-16 Ellem Ind Farmaceutica TRIPEPTIDE HAVING AN IMMUNOSTIMULATING ACTIVITY
BE1000263A4 (en) * 1986-04-09 1988-09-27 Ellem Ind Farmaceutica A tripeptide immunostimulatory activity.
EP0335662A1 (en) * 1988-03-28 1989-10-04 Btg International Limited Peptides
WO1989009226A1 (en) * 1988-03-28 1989-10-05 National Research Development Corporation Peptides
US5389615A (en) * 1988-03-28 1995-02-14 British Technology Group Ltd. Peptides and pharmaceutical composition thereof in the treatment of pain
US5580855A (en) * 1988-03-28 1996-12-03 British Technology Group Limited Peptides
EP0392095A2 (en) * 1989-02-10 1990-10-17 SCLAVO S.p.A. Tuftsin analogues and vaccines containing these as adjuvants
EP0392095A3 (en) * 1989-02-10 1991-01-30 SCLAVO S.p.A. Tuftsin analogues and vaccines containing these as adjuvants
EP1556074A2 (en) * 2001-08-30 2005-07-27 Chay 13 Medical Research Group N.V. Casein derived peptides and uses thereof in therapy
EP1556074A4 (en) * 2001-08-30 2008-05-07 Chay 13 Medical Res Group N V Casein derived peptides and uses thereof in therapy

Also Published As

Publication number Publication date
JPS6053040B1 (en) 1985-11-22
CH605672A5 (en) 1978-10-13
CA999851A (en) 1976-11-16
DE2124003A1 (en) 1972-06-22
US3778426A (en) 1973-12-11
FR2118134B1 (en) 1975-10-10
DE2124003C2 (en) 1982-04-22
GB1364497A (en) 1974-08-21

Similar Documents

Publication Publication Date Title
FR2118134B1 (en)
AR204384A1 (en)
ATA96471A (en)
AU1146470A (en)
AU1473870A (en)
AU1517670A (en)
AU1833270A (en)
AU1336970A (en)
AU1326870A (en)
AU1716970A (en)
AR195465A1 (en)
AU1603270A (en)
AU1841070A (en)
AU1083170A (en)
AU1064870A (en)
AU1004470A (en)
AU1969370A (en)
AU2130770A (en)
ATA672271A (en)
AU1943370A (en)
AU2131570A (en)
AU1918570A (en)
AU1328670A (en)
AU1881070A (en)
AU1879170A (en)

Legal Events

Date Code Title Description
ST Notification of lapse